22 November 2013

BioSense Testing at 2013 ISDS Conference

The BioSense Redesign team would like to invite you to participate in our one-on-one user testing sessions at the upcoming ISDS conference in New Orleans, Louisiana, on Thursday, December 12, and Friday, December 13, 2013. This invitation provides further details. Thank you for your interest.

The CDC BioSense Program provides local, state, and federal partners a timely regional and national picture of trends in disease syndromes and situation awareness. BioSense has been redesigned by RTI International to shift the program's focus to meet the needs of stakeholders and end users in state and local health departments, CDC programs, hospitals, and other federal agencies (i.e., DoD and VA) to improve regional and national coverage. You can learn more about the Program by watching this brief video: http://vimeo.com/32199430 and visiting the BioSense Collaboration Web site https://sites.google.com/site/biosenseredesign/.

A major part of the redesign is conducting one-on-one user testing sessions with potential BioSense 2.0 users. At ISDS this year, we are focusing on the BioSense 2.0 Collaboration Web site, a resource that provides information about BioSense 2.0 to all interested parties. The results of the testing sessions will allow us to make useful enhancements and updates to the Web site.

By taking part in this evaluation, you have the opportunity to influence the design of the BioSense 2.0 Collaboration Web site. If you are interested in meeting with us, please contact us at BioSense.User@gmail.com and we will work with you to schedule a convenient time.

During the Session:
We will describe real-world scenarios to you and ask you to use the Web site to work through the activities. We’ll ask you to describe your experience as you use the site. In addition, the computer that you use to complete the tasks on the BioSense 2.0 Collaboration Web site will capture data such as time-on-task, navigation of the site, and visual areas of interest that will help us to improve the site.

No comments:

Post a Comment